Navigation Links
Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet
Date:6/17/2013

tis may be a forerunner of pancreatic cancer.  Pancreatic cancer is among the deadliest of all cancers, for which there are no satisfactory treatments. 

The complaint charges that the defendants were aware of the serious health risks associated with the use of these drugs, and concealed them from the public, prescribing doctors and governmental regulatory bodies.  It not only seeks damages for the pain and suffering and economic loss sustained by the Cataletto family but also punitive or punishment damages based on "disregard for human life."

"From our examination of the data, it appears to us that there has been overpromotion and under warning by the sellers of these and other drugs in the incretin category," says Paul D. Rheingold, senior partner in the law firm.  The firm specializes in representing persons injured by drugs and medical devices."  It is currently heavily involved with litigation involving metal-on-metal hips made by DePuy and Stryker.

Attention is also being directed now to other drugs in the incretin category, including Victorza and Onglyza.  The manufacturers of all of these drugs announced in mid-June that they would cooperate with the Food and Drug Administration and the American Diabetes Association in studying the potential link between use of incretins and the development of pancreatic cancer. 

For more information please visit our website www.rheingoldlaw.com or contact our firm
Rheingold, Valet, Rheingold, McCartney & Giuffra LLP 
113 East 37th Street, New York, NY 10016  
Tel. No.:  1(800)349-0004/(212)684-1880


 


'/>"/>
SOURCE Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
8. Comments on The Nobel Prize Assemblys Response to the Lawsuit Filed by Life Scientist, Dr. Rongxiang Xu
9. China Nepstar Chain Drugstore Filed 2012 Annual Report on Form 20-F
10. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
11. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... July 2, 2015 ResMed Inc. (NYSE: RMD ... and fiscal year ended June 30, 2015 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... 50% Survival in Valortim-Treated,Animals , PRINCETON, N.J. ... Medarex,Inc. (Nasdaq: MEDX), a leading monoclonal antibody ... company dedicated,to the development of biodefense countermeasures, ... antibody product candidate,being developed for the prevention ...
... to Guard Against,Hospital Infections, KANSAS CITY, Kan., April ... top ten leading causes of death in the,United ... There,are countless stories about patients who go into ... circumstances. As a,patient, knowing the right questions to ...
Cached Medicine Technology:Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Six Important Things to Know About Preventing Hospital Infections 2Six Important Things to Know About Preventing Hospital Infections 3
(Date:7/6/2015)... ... , ... Diabetes affects many of us and the Glycemic Load and Alkaline ... majority of which are Type 2. However, eight million do not know they have ... prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar levels and in ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, ... hospice patients and adult day center participants. , The Music & Memory program is ... their families and volunteers. Music & Memory is a non-profit organization that helps provide ...
(Date:7/6/2015)... Harlingen, Texas (PRWEB) , ... July 06, 2015 , ... ... a thought-provoking look into the economic transformation associated with the U.S. economy over the ... macroeconomic consequences associated with its use. In many ways, the book is a time ...
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... City Sports, ... City Sports will co-produce two training clinics for first-time triathletes this summer with ethos, ... will take place on Thursday, July 9, at 6:00 p.m. at the North End ...
Breaking Medicine News(10 mins):Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3
... initiatives should target both coverage and access to health care ... do not have health insurance and no regular source of ... needs, researchers at the University of Michigan C.S. Mott Children,s ... to do more to safeguard the health of vulnerable children, ...
... BCRX ) today announced that its fourth quarter and ... February 6, 2009. Following the release, BioCryst will host a ... to discuss the financial results and provide an update on ... P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief ...
... novel Photoconductive Stimulation Device (PSD) was highlighted in the ... Ca2+ Waves Guide CNS Growth Cones to Remote Regions ... 2008 issue of The Public Library of Science One ... mediating axonal guidance. It is known that the path ...
... The assets of Trimlife ( www.trimlife.com ), a ... by The Neutraceutical Company, LLC of Fort Lee, NJ, ... the successful weight-loss product Lipitone ( www.lipitone.com ) and ... well as introduce additional wellness products and services on ...
... (Nasdaq: LCAV ), a leading provider of laser ... announced that it will release fourth quarter and full year ... 10, 2009. A conference call and webcast to discuss ... 2009 at 10:00 a.m. Eastern time.To access the conference call, ...
... Calif., Jan. 30 Patient Safety Technologies (OTC ... closed on $2.55 million of new senior notes ... from the financing will go primarily towards funding ... SurgiCount Medical, the leading provider of tracking ...
Cached Medicine News:Health News:Medical Needs of 6.2 Million U.S. Kids Go Unmet 2Health News:BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009 2Health News:BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009 3Health News:Novel Photoconductive Cellular Depolarization Technology Reveals Insight Into Neuronal Growth, Guidance, and Regeneration 2Health News:The Neutraceutical Company, LLC Grows Wellness Enhancement Business with Acquisition of North Dakota Based Trimlife.com 2
This storage freezer, which is based on our premium freezer line, maintain red cells safely below regulatory standards at -86C (-123F). Recorder is standard for model 8590. Model 8590 is UL Listed, C...
... precise requirements of blood banking and ... Equipment meets American Association of Blood ... (ANRC) and U.S. Food & Drug ... and platelet incubators feature alarm systems ...
... the precise requirements of blood banking ... Bank Equipment meets American Association of ... Cross (ANRC) and U.S. Food & ... freezers, and platelet incubators feature alarm ...
... the precise requirements of blood banking ... Bank Equipment meets American Association of ... Cross (ANRC) and U.S. Food & ... freezers, and platelet incubators feature alarm ...
Medicine Products: